FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes derivatives of aniline of the formula (I) where R1 means SR6 or NRYR8; R6 means direct or branched alkyl group and others; R7 means hydrogen atom, direct or branched alkyl group and others; R8 means hydrogen atom, direct or branched alkyl group; R2 means hydrogen atom, direct or branched group and others; R3 means hydrogen atom or direct or branched alkyl group and others; R4 means hydrogen atom, direct or branched alkyl group and others; R5 means hydrogen atom, direct or branched alkyl group and others; Y1,Y2,Y3,Y4 mean hydrogen, halogen atom, hydroxy-group and others; n and m each = 0 or 1, or possible stereoisomers or optically active forms of compounds or their pharmaceutically acceptable salts. Compounds show strong inhibitory effect on activity of NO-synthase and they are used as therapeutic agents for treatment of patients with cerebrovascular diseases, for example, cerebral hemorrhage, cerebral infarction, brain edema and others. EFFECT: new compounds, valuable medicinal properties. 95 cl, 2 dwg, 51 tbl, 656 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF INDOLINE-2-ONE AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS | 1994 |
|
RU2128170C1 |
DERIVATIVES OF AROMATIC AMINES ELICITING EFFECT INHIBITING OAC, METHOD OF THEIR SYNTHESIS AND INHIBITOR OF нOAC | 1997 |
|
RU2193554C2 |
SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
BENZENE DERIVATIVES | 1994 |
|
RU2127254C1 |
22-THIAVITAMIN D DERIVATIVES, METHOD OF PREPARATION THEREOF, METHOD FOR PREPARATION OF COMPOUNDS, AND COMPOUNDS | 1995 |
|
RU2142941C1 |
NOVEL WATER-SOLUBLE PRODRUGS | 2005 |
|
RU2413731C2 |
METHOTREXATE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2109016C1 |
DERIVATIVES OF VITAMIN D, COMPOUNDS PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, TREATMENT METHOD | 2001 |
|
RU2230738C9 |
NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
Authors
Dates
2001-05-27—Published
1995-12-12—Filed